Pfizer
Ofer Waks is a Senior Director at Pfizer, leading Global Medical Partnerships and Digital Products since April 2018. With a strong background in digital strategy and innovation, Ofer has successfully managed the development and launch of regulated digital medicine products and external partnerships within the healthcare domain. Prior experience includes roles at Shire, where responsibilities involved corporate development and product management in Oncology, and Biogen Idec, focusing on commercial launch management. Ofer's early career included roles at Novartis, PPD, and Maccabi Health Services, demonstrating expertise in clinical research, marketing strategy, and pharmacology. Educational qualifications include an MBA in Healthcare Management from The Wharton School and a Bachelor of Pharmacy from Ben-Gurion University of the Negev.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.